394 related articles for article (PubMed ID: 16879035)
21. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
22. Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis.
de Bruijn HS; Kruijt B; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photochem Photobiol Sci; 2007 Aug; 6(8):857-64. PubMed ID: 17668116
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty.
Kwon OC; Yoon HJ; Kim KH; Kim HT; Yoon YH; Kim JK
Photochem Photobiol; 2008; 84(5):1209-14. PubMed ID: 18363621
[TBL] [Abstract][Full Text] [Related]
24. Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus.
van den Boogert J; van Hillegersberg R; van Staveren HJ; de Bruin RW; van Dekken H; Siersema PD; Tilanus HW
Br J Cancer; 1999 Feb; 79(5-6):825-30. PubMed ID: 10070876
[TBL] [Abstract][Full Text] [Related]
25. Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.
Bourre L; Thibaut S; Briffaud A; Lajat Y; Patrice T
Pharmacol Res; 2002 Feb; 45(2):159-65. PubMed ID: 11846630
[TBL] [Abstract][Full Text] [Related]
26. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo.
Finlay JC; Conover DL; Hull EL; Foster TH
Photochem Photobiol; 2001 Jan; 73(1):54-63. PubMed ID: 11202366
[TBL] [Abstract][Full Text] [Related]
27. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.
Marcus SL; Sobel RS; Golub AL; Carroll RL; Lundahl S; Shulman DG
J Clin Laser Med Surg; 1996 Apr; 14(2):59-66. PubMed ID: 9484077
[TBL] [Abstract][Full Text] [Related]
29. Fractionated illumination at low fluence rate photodynamic therapy in mice.
Middelburg TA; Van Zaane F; De Bruijn HS; Van Der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; De Haas ER; Robinson DJ
Photochem Photobiol; 2010; 86(5):1140-6. PubMed ID: 20553407
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
[TBL] [Abstract][Full Text] [Related]
31. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT.
Wang KK; Cottrell WJ; Mitra S; Oseroff AR; Foster TH
Lasers Surg Med; 2009 Nov; 41(9):686-96. PubMed ID: 19802891
[TBL] [Abstract][Full Text] [Related]
32. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.
van den Boogert J; Houtsmuller AB; de Rooij FW; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Surg Med; 1999; 24(1):3-13. PubMed ID: 10037346
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol.
Wołuń-Cholewa M; Butowska W; Warchoł W
Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756
[TBL] [Abstract][Full Text] [Related]
34. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
[TBL] [Abstract][Full Text] [Related]
35. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
37. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
38. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor model.
Zaak D; Sroka R; Stocker S; Bise K; Lein M; Höppner M; Frimberger D; Schneede P; Reich O; Kriegmair M; Knüchel R; Baumgartner R; Hofstetter A
Urol Int; 2004; 72(3):196-202. PubMed ID: 15084761
[TBL] [Abstract][Full Text] [Related]
40. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
